These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38780260)

  • 1.
    Cajas RA; Santos SSB; Espírito-Santo MCC; Garedaghi Y; de Moraes J
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0011424. PubMed ID: 38780260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.
    Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS
    Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparasitic properties of 4-nerolidylcatechol from Pothomorphe umbellata (L.) Miq. (Piperaceae) in vitro and in mice models with either prepatent or patent Schistosoma mansoni infections.
    Costa DS; Leal CM; Cajas RA; Gazolla MC; Silva LM; Carvalho LSA; Lemes BL; Moura RO; Almeida J; de Moraes J; da Silva Filho AA
    J Ethnopharmacol; 2023 Sep; 313():116607. PubMed ID: 37149066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
    Keiser J; Manneck T; Vargas M
    J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.
    Queiroz LS; Ferreira EA; Mengarda AC; Almeida ADC; Pinto PF; Coimbra ES; de Moraes J; Denadai ÂML; Da Silva Filho AA
    Parasitol Res; 2021 Apr; 120(4):1321-1333. PubMed ID: 33164156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
    de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
    Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Existing Drug Nifuroxazide as an Antischistosomal Agent:
    Roquini V; Mengarda AC; Cajas RA; Martins-da-Silva MF; Godoy-Silva J; Santos GA; Espírito-Santo MCC; Pavani TFA; Melo VA; Salvadori MC; Teixeira FS; Rando DGG; de Moraes J
    Microbiol Spectr; 2023 Aug; 11(4):e0139323. PubMed ID: 37409934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Callistemon citrinus aqueous extract on prepatent and patent infections with Schistosoma mansoni in experimentally infected mice.
    El-Refai SA; Atia AF; Mahmoud SF
    J Helminthol; 2019 Jul; 93(4):424-433. PubMed ID: 29716664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model.
    Lombardo FC; Perissutti B; Keiser J
    Eur J Pharm Biopharm; 2019 Sep; 142():240-246. PubMed ID: 31265895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO; Rawago FO; Makworo NK; Muok EMO
    Parasit Vectors; 2024 Jun; 17(1):279. PubMed ID: 38943214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of oral therapy on Mansonial Schistosomiasis using single dose of Balanites aegyptiaca fruits and praziquantel.
    Koko WS; Abdalla HS; Galal M; Khalid HS
    Fitoterapia; 2005 Jan; 76(1):30-4. PubMed ID: 15664459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel.
    Liang YS; Coles GC; Doenhoff MJ; Southgate VR
    Int J Parasitol; 2001 Sep; 31(11):1227-35. PubMed ID: 11513892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Parasit Vectors; 2020 Sep; 13(1):474. PubMed ID: 32933556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.
    Danso-Appiah A; De Vlas SJ
    Trends Parasitol; 2002 Mar; 18(3):125-9. PubMed ID: 11854090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
    Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
    Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antischistosomal properties of aurone derivatives against juvenile and adult worms of Schistosoma mansoni.
    Pereira VRD; da Silveira LS; Mengarda AC; Alves Júnior IJ; da Silva OOZ; Miguel FB; Silva MP; Almeida ADC; Torres DDS; Pinto PF; Coimbra ES; de Moraes J; Couri MRC; da Silva Filho AA
    Acta Trop; 2021 Jan; 213():105741. PubMed ID: 33159900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni.
    Portela J; Boissier J; Gourbal B; Pradines V; Collière V; Coslédan F; Meunier B; Robert A
    PLoS Negl Trop Dis; 2012; 6(2):e1474. PubMed ID: 22348155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.